Solid organ fabrication: comparison of decellularization to 3D bioprinting
Owner/Developer: BioMed Central
| Country: | United States of America |
|---|---|
| Languages: | English |
| Url: | http://biomaterialsres.biomedcentral.com/articles/10.1186/s40824-016-0074-2 |
| Description: |
Solid organ fabrication is an ultimate goal of Regenerative Medicine. Since the introduction of Tissue Engineering in 1993, functional biomaterials, stem cells, tunable microenvironments, and high-resolution imaging technologies have significantly advanced efforts to regenerate in vitro culture or tissue platforms. Relatively simple flat or tubular organs are already in (pre)clinical trials and a few commercial products are in market. The road to more complex, high demand, solid organs including heart, kidney and lung will require substantive technical advancement. Here, we consider two emerging technologies for solid organ fabrication. One is decellularization of cadaveric organs followed by repopulation with terminally differentiated or progenitor cells. The other is 3D bioprinting to deposit cell-laden bio-inks to attain complex tissue architecture. We reviewed the development and evolution of the two technologies and evaluated relative strengths needed to produce solid organs, with special emphasis on the heart and other tissues of the cardiovascular system. |
| Category: | Publication |
| Channel: | Website - Printed |
| Audience: | Scientists - Students - Industry - Researchers |
| User access: | Open access |
| Updating frequency: | 2016 |
| Relevance: | Replacement |
| Purpose: | Documentation and information |
| Technology/Tools: | 3D printing - Tissue engineering |
Did you find what you were looking for?
Yes, I found it! No, I did not!Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!
Please contact us by email if you have any questions.